Breadcrumb

Breadcrumbs

Press Releases

Search Results

Back to Press Releases
Showing 41 - 43 of 43 results.

You searched for : February 2020 to February 2021.

Daiichi Sankyo Submits Supplemental New Drug Application for Trastuzumab Deruxtecan in Japan for Tr ...

Daiichi Sankyo Submits Supplemental New Drug Application for Trastuzumab Deruxtecan in Japan for Treatment of Patients with HER2 Positive Metastatic Gastric Cancer Download the PDF version of...

Daiichi Sankyo Submits Application for CAR T Therapy Axicabtagene Ciloleucel for Treatment of Patie ...

Daiichi Sankyo Submits Application for CAR T Therapy Axicabtagene Ciloleucel for Treatment of Patients with Certain Relapsed/Refractory B-cell Lymphomas in Japan Download the PDF version of Article...

ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic ...

ENHERTU® Approved in Japan for Treatment of Patients with HER2 Positive Unresectable or Metastatic Breast Cancer Download the PDF version of Article March 25, 2020 Approval based on the pivotal...

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...